 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||||||||| MB04 (etanercept biosimilar) / Insud Pharma
New P3 trial: A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel (clinicaltrials.gov) - Sep 19, 2024
P3, N=458, Recruiting, Sponsor: mAbxience Research S.L.
- ||| MB04 (etanercept biosimilar) / Grupo Insud
New P1 trial: MB04-A-01-23: A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders (clinicaltrials.gov) - Apr 29, 2024
P1, N=132, Recruiting, Sponsor: mAbxience Research S.L.